University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Patient Understanding of Handouts at Different Reading Levels

Not Applicable

Completed

Conditions: Health Literacy

First Posted Date: 2025-03-25

Last Posted Date: 2025-04-03

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 156

Registration Number: NCT06736808

Locations: 🇺🇸
University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX, Raleigh, North Carolina, United States

Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine

Phase 4

Not yet recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: Morphine
Drug: Bupivacaine
Drug: Fentanyl
Drug: Hydromorphone

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 46

Registration Number: NCT06784180

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Affect-based Impulsivity in Borderline Personality Disorder

Not Applicable

Recruiting

Conditions: Borderline Personality Disorder (BPD)
Healthy Controls Group - Age and Sex-matched

First Posted Date: 2025-03-18

Last Posted Date: 2025-04-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 106

Registration Number: NCT06880640

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding

Not Applicable

Recruiting

Conditions: Malaria Infection
Malaria Falciparum

Interventions: Other: Long-lasting Insecticidal Net
Drug: Dihydroartemisinin piperaquine
Combination Product: Dihydroartemisinin piperaquine + Bacillus thuringiensis israelensis

First Posted Date: 2025-03-11

Last Posted Date: 2025-03-12

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 36000

Registration Number: NCT06870344

Locations: 🇺🇬
Mbarara University of Science and Technology (MUST), Mbarara, Uganda

Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

Phase 4

Not yet recruiting

Conditions: Pouchitis
Pouches, Ileoanal
Pouch, Ileal

Interventions: Drug: Mirikizumab - Intravenous (IV)
Drug: Mirikizumab - Subcutaneous (SC)

First Posted Date: 2025-03-07

Last Posted Date: 2025-03-07

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 25

Registration Number: NCT06864403

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Oral Ketorolac for IUD Pain Reduction

Phase 2

Not yet recruiting

Conditions: IUD Insertion Pain

Interventions: Drug: Ketorolac
Drug: Placebo

First Posted Date: 2025-02-28

Last Posted Date: 2025-02-28

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 108

Registration Number: NCT06853327

Locations: 🇺🇸
University of North Carolina - Hillsborough Campus, Hillsborough, North Carolina, United States

Preventing Type 2 Diabetes in Black Emergent Adult

Not Applicable

Not yet recruiting

Conditions: Type 2 Diabetes Mellitus
Binge-Eating Disorder
Binge Eating
Obesity

First Posted Date: 2025-02-26

Last Posted Date: 2025-02-26

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 100

Registration Number: NCT06848244

Locations: 🇺🇸
UNC-Chapel Hill, Chapel Hill, North Carolina, United States

Testing Ultraprocessed Food Labels in Chile

Not Applicable

Not yet recruiting

Conditions: Diet, Healthy

First Posted Date: 2025-02-24

Last Posted Date: 2025-04-23

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 3306

Registration Number: NCT06842680

Locations: 🇺🇸
The University of North Carolina at Chapel Hill's Gillings School of Global Public Health, Chapel Hill, North Carolina, United States

Testing Non-nutritive Sweetener Labels in Chile

Not Applicable

Not yet recruiting

Conditions: Diet, Healthy

First Posted Date: 2025-02-24

Last Posted Date: 2025-04-24

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 3306

Registration Number: NCT06842693

Locations: 🇺🇸
The University of North Carolina at Chapel Hill's Gillings School of Global Public Health, Chapel Hill, North Carolina, United States

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Phase 4

Not yet recruiting

Conditions: Smoke Exposure
Influenza

Interventions: Biological: LAIV nasal vaccine is chosen as a model viral infection
Other: Wood smoke
Biological: Placebo for LAIV nasal vaccine is chosen as a model viral infection
Other: Placebo for Wood Smoke (clean Air Exposure)

First Posted Date: 2025-02-24

Last Posted Date: 2025-02-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 112

Registration Number: NCT06841913

Locations: 🇺🇸
Human Studies Facility, Chapel Hill, North Carolina, United States

Home Terms & Conditions Privacy Policy